Introduction
============

An anesthetist\'s arsenal includes several local anesthetics for carrying out regional anesthesia, and these anesthetics require different times for achieving complete sensory and motor blocks as well as different acting times \[[@B1]\]; attempts to mix anesthetics with different properties were done earlier with the aim of summarizing their useful effects. The toxic action of local anesthetics, appearing as a result of unpremeditated intravascular injection as well as a result of preparation absorption, required research in order to identify low doses of local anesthetics for effectively blocking peripheral nerves \[[@B2]\].

Discrepant results have been published about the application of mixtures of various anesthetics for sciatic nerve block. Cuvillon et al. \[[@B3]\] noted that, if 20 ml of 0.75% ropivacaine (150 mg) is mixed with 20 ml of 2% lidocaine (with the addition of epinephrine at a ratio of 1 : 200,000), the time required for the blockade of the sciatic nerve beginning shortens significantly. However, the complete block developed in these observations to the 30th minute. Related to previous eye surgeries, a report was published that the time for the development and blockade duration compared when retrobulbar block was performed with ropivacaine and using a mixture (1 : 1) of bupivacaine and lidocaine \[[@B4]\]. Chelly \[[@B5]\] wrote that, to achieve surgical anesthesia of the sciatic nerve, 15-20 min are required if ropivacaine 0.75% is used and 10-20 min if 0.75% ropivacaine is mixed with 1.5% lidocaine. Although the report\'s author did not describe the amount, volume, and proportion of anesthetics, data were included about the quicker development of sensory block if lidocaine is mixed with bupivacaine for epidural blockade performance \[[@B6]\]. Data related to the application of preparation mixtures for peripheral blocks are very scarce. Taking into account the highly contradictory character of the available data about the effectiveness and expediency of local anesthetics mix as well as the opportunity to apply ultrasonic visualization during block performance, we see the need for a more detailed study into this problem.

The purpose of the double-blind randomized study was to measure the time required for the achievement of the complete sensory block of the sciatic nerve (sensory block as a result of local anesthetics mixture application: primary end point), postoperative analgesia duration, and time for the development of the sciatic nerve motor block (secondary end point), if ropivacaine is used and in comparison with the ropivacaine-lidocaine mixture in patients undergoing orthopedic and traumatologic operations.

Materials and Methods
=====================

Ethical approval for this study was acquired by the Ethical Committee of the Mogilev Regional Hospital, Belarus (President Dr. Alexandr R. Stolin), Protocol No. 30 on 5 September 2011. Patients were randomized before the operation with respect to the manner of sciatic nerve block using one of three solutions, whose descriptions were randomly placed in sealed envelopes prior to the operation. To determine the effect of the anesthetics mix, we created three groups of patients, with 20 anesthesia performances in each group A: block with 5 ml of 0.75% ropivacaine group B: block with 10 ml of 0.75% ropivacaine, and group C: block with 5 ml of 0.75% ropivacaine + 5 ml of 1% lidocaine. The block was performed for patients before the operation on account of post-traumatic injuries and the dysfunction of shin bones, the genu joint, the talocrural joint, and foot, moving the metal constructions away from the shin bones.

The criteria for the inclusion of patients in the research included destination to an operation requiring anesthesia and the presence of the patient\'s written informed consent for the kind of anesthesia and its probable complications. The criteria for the exclusion of patients included the patient\'s refusal to take the proposed kind of anesthesia, patients who are too young (age \< 18) or small (weight \< 50 kg), patients with a physical status value of ASA \> 3, patients with allergic reactions to the applied medications in anamnesis, coagulopathy, infectious skin lesions at the injection area, neurological or nerve-muscular diseases, heavy liver diseases or kidney deficiency, and the inability to cooperate in the process. The characteristics of the groups are shown in [Table 1](#T1){ref-type="table"}.

All anesthetic solutions were prepared by the anesthesiologist, who did not take part in the research. The composition of the solutions was as follows:

solution A: 5 ml ropivacaine - HCl - 0.75% (37.5 mg)solution B: 10 ml ropivacaine - HCl - 0.75% (75 mg)solution C: 5 ml ropivacaine - HCl - 0.75% (37.5 mg) + 5 ml lidocaine - HCl - 1% (50 mg)

With the aim of premedication, 0.5-0.8 mg of atropine and 10 mg of Diphenhydramine were injected intramuscularly 20-30 min before the block. All patients received injections via venous access through catheter installation in a peripheral vein. SpO~2~, electrocardiogram, and non-invasive arterial pressure were monitored. In order to sedate the patients, depending on their emotional state, 10 mg of Diazepam and/or 0.1 mg of Fentanyl was injected intravenously several minutes after the operation began.

Sciatic nerve block was performed using a posterior approach, with the patient lying on his/her belly, under ultrasonic control \[[@B7]\]. The Aloca SSC400 apparatus with an ultrasonic detector of 7.5 MHz was used for visualization. After getting a picture of the sciatic nerve, a 100 mm isolated injection needle (Stimuplex®, B. Braun Melsungen AG, Germany) connected to a neurostimulator (HNS 11, B Braun) was used to approach the nerve trunk until the appropriate group of muscles responded. The initial current strength was 0.4 mA (frequency 1 Hz, impulse length 100 µsec). After the muscular response and aspiration probe execution, a solution of local anesthetic was injected into the fascial sheath of the sciatic nerve (\"fascial plane concept\") \[[@B8]\]. All blockades were performed under ultrasonic guidance, and in all cases we observed a \"doughnut sign\" effect. The method was completely blind as the anesthetist who performed the blockage did not see the syringe with the anesthetic. The syringe was in an assistant\'s hand behind a screen. The beginning of the solution injection was designated as zero point for the time control. In all cases for providing operations on extremities, an additional block of the femoral nerve using a \"3-in-1\" block was performed, depending on the region of the surgical operation \[[@B9]\]. The additional block was carried out in the same manner-with 25 ml of lidocaine 1% with the addition of epinephrine (1 : 200,000). The quality of the femoral nerve block or lumbar plexus branches (obturative nerve, lateral cutaneous nerve of hip, femoral nerve) block was assessed at once after 15 min.

The primary end point of the research was the point in time when complete sensory block was achieved. A cutaneous sensitivity assessment was carried out every 2 min until the 65th min of the block. The following scale was used for sensory block assessment: \'++\' - complete sensory block (anesthesia); \'+\' - incomplete sensory block, patient is not able to differentiate the type of irritant; and \'-\' - cutaneous sensitivity is fully preserved. Assessment of the patient\'s reaction was made using a pinprick test.

The secondary end points in this research were the complete motor block and the end of the analgetic effect of the blockade. Motor block assessment was carried out every 2 min until the 65th min after the local anesthetic injection, using the following scale: \'++\' - movements totally absent; \'+\' - movements preserved partly or not coordinated; \'-\' - movements fully preserved. Patients were asked to do a plantar flexion of the foot-tibial nerve and dorsiflexion with the common peroneal nerve. Both sensitivity and motor activity assessments were carried out by an independent anesthesiologist who did not take part in the research.

The duration of the postoperative analgesia was assessed through inquiry of the patient after surgery. Inquiry was done every 30 min by an independent anesthesiologist who did not take part in the research. The moment the patient started to complain about the sensation of pain in the operated region was noted as the end point of the regional block analgetic effect. Pain sensation was assessed according to the visual analogous scale (VAS), ranging from 0 mm (no pain) to 10 mm (intolerable pain). When pain sensation occurred in the region of the postoperative wound (1-2 points), 1 ml of 2% promedol was injected intramuscularly at 6 h intervals as an analgesia. We did not register the duration of the sensory and motor blocks.

Statistic processing of the data was carried out using Statistica 7.0 software. Three groups of patients were compared using the non-parametric method of a Kruskal-Wallis ANOVA. The zero hypothesis about the absence of differences was accepted when P \> 0.05. If P \< 0.05, the zero hypothesis was rejected, the differences between groups were accepted as statistically significant and a pairwise comparison of the groups was carried out using a non-parametric Mann-Whitney test. The data were figured as median and quartiles (25^th^ and 75^th^ percentiles).

Results
=======

The research involved 60 patients. No differences existed between groups in terms of gender, body weight, age, or ASA classification. In all patients, the sciatic nerve was localized using ultrasonic pointing, and muscular response to electric stimulation was achieved. During anesthesia, the indices for SPO~2~, electrocardiogram, and non-invasive arterial blood pressure did not decline from normal rates (the data are not provided here).

The complete sensory block (++) developed after 45 (40-48) min in group A, after 30 (28-30) min in group B, and after 12 (10-13) min in group C ([Fig. 1](#F1){ref-type="fig"}). Reliable differences were observed among groups, P \< 0.05 (P = 0.000).

The time for motor block development was 55 (50-60) min in group A, 35 (34-37) min in group B, and 14 (12-17) min in group C. We noted a reliable decrease in time as required for achieving the complete motor block of the sciatic nerve ([Fig. 2](#F2){ref-type="fig"}). The differences among the groups were reliable, P \< 0.05 (P = 0.000).

Regional anesthesia duration in the postoperative period was 8 (7.5-8.0) h for patients in group A, 8 (7.0-8.5) h for patients in group B, and 8 (7.0-8.5) h for patients in group C. No reliable differences in anesthesia duration occurred among the groups at P \> 0.05 (P = 0.82).

Discussion
==========

As stated by Taboada et al. \[[@B10]\], during sciatic nerve block using the subgluteal approach, the minimal volume for anesthesia development is 12 ± 3 ml of 1.5% mepivacaine. Latzke et al. \[[@B11]\] found that, for successfully blocking the sciatic nerve at the level of middle hip, the sufficient volume of the local anesthetic is less than 5 ml (1.5% mepivacaine). Our data showed that application of 5 ml of 0.75% ropivacaine in the gluteal area leads to a complete blockage of the sciatic nerve. Thus, we succeed to reduce the volume of 0.75% ropivacaine to 5 ml and reduce the amount to 37.5 mg while retaining the effective blockage of the sciatic nerve.

In our opinion, reducing the time required for the complete block development in group B compared to group A is associated with the application of twice as much ropivacaine in B as in A. The available literature data concerning this area of anesthesia is extensive. Previously published data obtained during the blockage of the humeral plexus by using the axillary approach showed that the rate of anesthesia development does not depend on the amount (mg) of local anesthetic \[[@B12],[@B13]\]. Slower development of motor and sensory block was noted by Riazi et al. \[[@B14]\], when 5 ml of ropivacaine was applied instead of 20 ml in the humeral plexus blockage. It should be noted that these data were obtained in the blockage of nerves with a small diameter. Taboada Muniz et al. \[[@B15]\] stated that the application of different volumes and concentrations of local anesthetic in sciatic nerve block according to Labat changes the time of anesthesia. As noted by Latzke et al. \[[@B11]\], the amount of anesthetic in sciatic nerve blockage has not yet been shown to have an effect on the time of sensory block development, but this aspect, as the author wrote, needs additional research.

According to Moayeri and Groen \[[@B16]\], the proportion of non-neural and neural tissue in the sciatic nerve is a factor influencing the rate of block development. In addition, the more non-neural tissue there is, the slower the anesthesia develops because the connective tissue is a barrier for local anesthetic diffusion. Considering that the diameter of the sciatic nerve is several times larger than that of the nerves of the humeral plexus in the axillary area, the amount of local anesthetic (mg) will likely influence the time of its diffusion through the sheath of nerves with larger diameters. According to Sala-Blanch et al. \[[@B17]\], during sciatic nerve block in the popliteal pit area by using the application of 20 ml of 1.5% mepivacaine, the anesthesia of the nerve developed after 15 min. The data collected by Taboada Muniz et al. \[[@B15]\] in terms of the influence of different volumes and concentrations of the time for block development, along with our application of ropivacaine (as an anesthetic agent with a subsequent effect), explain the longer time required for complete sensory and motor block development in groups A and B \[sensory block: 45 (40-48) and 30 (28-30) min accordingly\]. Thus, the available published data are discrepant and diverse. Our results are similar to the results described by Riazi et al. \[[@B14]\]. It is evident that the question about the effect of local anesthetic volume and amount of time required for peripheral nerve block development (in particular, the sciatic nerve) needs additional investigation.

The rate of complete development of sciatic nerve block was higher in group B, as explained by the application of the mixture of lidocaine and ropivacaine that we proposed. This mixture contained 50 mg of lidocaine and 37.5 mg of ropivacaine. It is evident that the need for adjuvant epinephrine in addition to the anesthetics mixture in previous research \[[@B3]\] stemmed from the probable summary effect of system toxicity of both anesthetic agents \[[@B2]\] and due to the sciatic nerve block performed in combination with a femoral nerve block. To date, the reduced volume and amount of local anesthetic agents per blockage has been impossible because blockades were performed only with the use of an electric stimulator of the peripheral nerves. Thus, the addition of epinephrine to the mixture of anesthetics equilibrates the main advantage of lidocaine. The application of a small quantity and volume of lidocaine and ropivacaine for sciatic nerve block under ultrasonic control decreases the risk of system toxicity of the preparations and removes the need to add epinephrine to the anesthetics mixture. The last factor (absence of epinephrine) promotes faster blockage development.

Thus, we decreased the time for achieving complete sensory block, which has special significance in the everyday anesthetist\'s practice. Often when a continuous stream of patients comes into the traumatological operating room, the long time required for achieving complete sensory block development leads to starting operations late, which can decrease the effectiveness of operation brigade work.

Contradictory data about block duration depending on local anesthetic volume during the humeral plexus block were obtained by Ponrouch et al. \[[@B12]\] and Gauiter et al. \[[@B18]\]. As Ponrouch et al. noted, humeral plexus block duration decreases as the applied volume of 1.5% mepivacaine decreases (time of postoperative analgesia was not assessed) \[[@B12]\]. In the humeral plexus block using the interscalene approach, when 5 ml of 0.75% naropin was applied, block duration (9.9 \[5-19\] hours) and post-operation analgesia (9.9 ± 3.7 hours) did not change in comparison with blockades when performed using standard volumes (20-30 ml) of 0.75% ropivacaine \[[@B18]\]. In the sciatic nerve block, we obtained results similar to those of Gauiter et al. \[[@B18]\]. It is possible that analgesia time duration does not depend on the amount of local anesthetic, if this amount is higher than the critical one. However, this question requires more detailed research. In conclusion, we demonstrated that the mix of ropivacaine (5 ml of 0.75%, 37.5 mg) and lidocaine (5 ml of 1%, 50 mg) leads to a sufficient decrease in the time required for complete sensory and motor block development during sciatic nerve blockade, with no decrease in the time required for post-operation analgesia. The mechanism of such an effect requires additional research.

![Change in onset time of sciatic nerve sensory block achievement depending on the applied solutions. Horizontal axis: the kind of solution (5 ml = 5 ml of 0.75% ropivacaine; 10 ml = 10 ml of 0.75% ropivacaine; 5 + 5 = mixture of 5 ml of 0.75% ropivacaine and 5 ml of 1% lidocaine); vertical axis: time of sensory block, approaching min.](kjae-65-42-g001){#F1}

![Change in onset time of sciatic nerve motor block achievement depending on the applied solutions. Horizontal axis: the kind of solution (5 ml = 5 ml of 0.75% ropivacaine; 10 ml = 10 ml of 0.75% ropivacaine; 5 + 5 = mixture of 5 ml of 0.75% ropivacaine and 5 ml of 1% lidocaine); vertical axis: time of motor block, approaching min.](kjae-65-42-g002){#F2}
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Characteristics of the Studied Patient Groups
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Group A: block with 5 ml of 0.75% ropivacaine, Group B: block with 10 ml of 0.75% ropivacaine, Group C: block with 5 ml of 0.75% ropivacaine + 5 ml of 1% lidocaine. The data were figured as median and quartiles (25th and 75th percentiles).
